A novel multigene panel (Sig27) robustly predicts poor prognosis of renal cell carcinoma via high-level associations with immunosuppressive features
Sig27 is a novel and effective pan-RCC biomarker with high-level associations with RCC immunosuppressive features.
Authors
- Sandra Vega Neira
- Yingying Su
- Damu Tang (ORCID: https://orcid.org/0000-0002-3282-9521)
- Bobby Shayegan (ORCID: https://orcid.org/0000-0001-9570-610X)
- Ying Dong (ORCID: https://orcid.org/0000-0002-0608-2815)
Institutions
- St. Joseph's Hospital (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- McMaster University (CA)
Publication Details
- Journal
- BJC Reports
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1038/s44276-025-00128-3
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Canadian Institutes of Health Research